No abstract available
Keywords:
epidemiology; hydroxychloroquine; lupus erythematosus, systemic.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antirheumatic Agents / therapeutic use
-
Azathioprine / therapeutic use
-
Betacoronavirus
-
COVID-19
-
COVID-19 Testing
-
Clinical Laboratory Techniques
-
Cohort Studies
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / physiopathology
-
Cough / physiopathology
-
Cyclosporine / therapeutic use
-
Diarrhea / physiopathology
-
Dysgeusia / physiopathology
-
Dyspnea / physiopathology
-
Fatigue / physiopathology
-
Female
-
Fever / physiopathology
-
Glucocorticoids / therapeutic use
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Immunosuppressive Agents / therapeutic use
-
Incidence
-
Intensive Care Units
-
Italy / epidemiology
-
Lupus Erythematosus, Systemic / drug therapy
-
Lupus Erythematosus, Systemic / epidemiology*
-
Male
-
Methotrexate / therapeutic use
-
Middle Aged
-
Mycophenolic Acid / therapeutic use
-
Olfaction Disorders / physiopathology
-
Pandemics
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / physiopathology
-
Prednisone / therapeutic use
-
Respiratory Distress Syndrome / epidemiology*
-
SARS-CoV-2
-
Telemedicine*
Substances
-
Antirheumatic Agents
-
Glucocorticoids
-
Immunosuppressive Agents
-
Hydroxychloroquine
-
Cyclosporine
-
Mycophenolic Acid
-
Azathioprine
-
Prednisone
-
Methotrexate